NCT04352335View on ClinicalTrials.gov

Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Advanced Lung Cancer
Trial Locations (1)

Unknown

Chung Shan Medical University Hospital, Taichung

All Listed Sponsors
lead

Chung Shan Medical University

OTHER

NCT04352335 - Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator | Biotech Hunter | Biotech Hunter